Medical News

RSS

Unilife initiates Unifill syringe production for pharmaceutical companies

Unilife Corporation today announced it has commenced initial production of the Unifill ready-to-fill syringe at its FDA-registered manufacturing facility in York, Pennsylvania.

30 Mar 2011

New study: Periodontal therapy can help reduce medical costs for patients with diabetes

The results from a new CIGNA study support that there is a potential association between treated periodontal disease and reduced medical costs for patients with diabetes.

30 Mar 2011

Canadian Cancer Society applauds Ontario government for allocating new funding for Breast Screening Program

The Canadian Cancer Society is pleased women with a family history of breast cancer and other higher-risk women will now have access to high-quality breast screening through the Ontario Breast Screening Program.

30 Mar 2011

Merck submits Erbitux indication extension to EMA for NSCLC treatment

Merck Serono, a division of Merck KGaA, Darmstadt, Germany, announced today that it has submitted an indication extension to the European Medicines Agency for the approval of Erbitux in combination with standard 1st line platinum-based chemotherapy in patients with advanced or metastatic non-small cell lung cancer with high epidermal growth factor receptor expression.

30 Mar 2011

Accelrys announces Modeling and Simulation Suite for optimizing R&D value chain

Accelrys, Inc., a leading scientific enterprise R&D software and services company, today announced the Accelrys Modeling and Simulation Suite, a pillar of the new Accelrys Enterprise R&D Architecture.

30 Mar 2011

Pathfinder cell-based therapy reverses diabetes in mouse model

Pathfinder, LLC, a private biotechnology company focused on the treatment of diseases characterized by organ-specific cell damage, today announced publication of promising preclinical data demonstrating that the Company's unique cell-based therapy is able to completely reverse diabetes in a mouse model.

30 Mar 2011

SAMHSA publishes strategic initiatives paper on nation's behavioral health care system

The Substance Abuse and Mental Health Services Administration today published its strategic initiatives paper - an overview of SAMHSA's goals, priorities and action steps for accomplishing its mission of reducing the impact of substance abuse and mental illness on America's communities.

30 Mar 2011

Insect Shield Repellent Apparel can protect against tick bites

A pilot study shows clothes treated with long-lasting insect repellant appear to offer outdoor workers significant protection against tick bites.

30 Mar 2011

ADI, Fondation Médéric Alzheimer honor Britain's psychiatry professor with international award

Dr. Sube Banerjee, one of the world's leading experts on Alzheimer's disease is the recipient of an international award for the best evidence-based psychosocial intervention for people with dementia and their caregivers.

30 Mar 2011

UT Southwestern Medical Center tops best hospital rankings for Dallas-Fort Worth

UT Southwestern Medical Center ranked as the best hospital in Dallas-Fort Worth in the newly expanded U.S. News & World Report's America's Best Hospitals rankings for 52 metropolitan areas.

30 Mar 2011

Vexim granted FDA approval for COHESION bone cement

Vexim specialises in medical instruments and the minimally invasive treatment of vertebral fractures. The company recently announced that it had been awarded FDA certification for its flagship product COHESION™, a bone cement for injection into the vertebra for its fixation following minimally invasive spine repair with the company's SpineJack® device, or following conventional vertebroplasty.

30 Mar 2011

Almac inaugurates new CLIA registered laboratory

Almac's Diagnostics business unit today announced the opening of its CLIA registered laboratory.

30 Mar 2011

The Wall Street Journal: Medicare records show trail of troubling surgeries

The Wall Street Journal continues its examination of Medicare's claims databases to uncover potentially fraudulent activities. Meanwhile, The Miami Herald reports on one alleged fraud perpetrator who is now awaiting trail.

30 Mar 2011

Positive preliminary results from Presidio's PPI-461 Phase 1b trial against HCV

Presidio Pharmaceuticals, Inc. announced today positive preliminary results from a Phase 1b clinical trial of PPI-461, a novel HCV NS5A inhibitor for the treatment of patients with chronic hepatitis C.

30 Mar 2011

Pelvic arterial embolization therapy effective treatment for postpartum hemorrhage

Pelvic arterial embolization or PAE, a minimally invasive, life-saving therapy, is a safe and effective treatment for postpartum hemorrhage, say researchers at the Society of Interventional Radiology's 36th Annual Scientific Meeting in Chicago, Ill.

30 Mar 2011

New research measures direct radiation doses in patients during endovascular procedures

New research published in the April 2011 issue of the Journal of Vascular Surgery®, the official publication of the Society for Vascular Surgery®, directly measured the radiation doses for patients and operators during complex endovascular procedures.

30 Mar 2011

Valeant receives European Commission marketing authorization for Trobalt

Meda's partner for retigabine, Valeant Pharmaceuticals International, Inc., today announced that the European Commission has granted the marketing authorization for Trobalt™ (retigabine) in the epilepsy therapy area.

30 Mar 2011

Research: Women's body appreciation indirectly connected to their BMI

Women's appreciation of their bodies is only indirectly connected to their body mass index (BMI), a common health measure of weight relative to height, according to recent research.

30 Mar 2011

Cephalon receives unsolicited proposal from Valeant

Cephalon, Inc. confirmed today that it received an unsolicited proposal from Valeant Pharmaceuticals International, Inc., on March 18th to acquire the Company for $73 per share and a second unsolicited proposal on March 25th to either acquire the Company for $73 per share or to purchase Cephalon's non-oncology related assets for $2.8 billion. On March 29th, Valeant announced an unsolicited proposal to acquire all of the outstanding shares in the Company for $73 per share.

30 Mar 2011

Navy sonar experts develop new medical device for stroke detection

A medical device developed by retired U.S. Navy sonar experts, using submarine technology, is a new paradigm for the detection, diagnosis and monitoring of stroke, says a team of interventional radiologists at the Society of Interventional Radiology's 36th Annual Scientific Meeting in Chicago, Ill.

30 Mar 2011